Jerome J. Lande

Jerome J. Lande (board member) discloses dealings in 2 companies, chiefly Itron, Inc. and CONMED Corp. We count 39 filings; the first trade dates from 1 January 2016 and the latest from 1 October 2026.

Sales make up the whole of the open-market record (3 sales, €57.4M). Other entries cover 27 share grants and 6 option exercises.

On 5 October 2026 came the latest disclosure, a share grant in Itron, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.